Alan Guttmacher, director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, discussed the future implications of the Human Genome Project with a score of Northeastern students and researchers.
The Centers for Disease Control and Prevention recently released a new report on the impact of antibiotic resistant bacteria on national health. We asked assistant professor Betsy Hirsch to explain its significance and what it means for the public.
Wednesday’s 7th annual Bouvé Health Fair and Flu Clinic will feature free flu shots and health screenings as well as prizes for some 250 students, faculty, and staff.
Local and national healthcare leaders convened at a kick-off event for a new Northeastern program aimed at integrating oral health into overall healthcare practice and education.
Northeastern hosted the first International Translational Nanomedicine Conference over the weekend, welcoming researchers and industry experts from around the globe.
Pharmacy graduate Nick O’Donnell earned an award at the RISE:2013 expo this spring for his work investigating the adverse effects of intravenous sedatives.
Leaders of flourishing healthcare companies shared their success stories on Thursday evening at an annual event hosted by the Health Sciences Entrepreneurs, an alumni group dedicated to fostering entrepreneurship in the healthcare field.
Pharmaceutical sciences professor Barbara Waszczak and graduate student Brendan Harmon devised an intranasal gene therapy that targets the underlying cause of Parkinson’s disease, not just its symptoms.
The Bouvé College of Health Sciences supports a collaborative approach to healthcare and research, as demonstrated at the 6th annual Interprofessional Research Symposium last week.
Professor Gary Young and his colleagues at Northeastern are the first in the nation to analyze hospitals’ community benefits practices, which are intimately linked with their tax-exempt status.
In a new paper, Distinguished Professor Mansoor Amiji and his collaborators present a drug-delivery system they believe can specifically target only tumors and turn off the cancer cells’ “superpowers” that allow them to grow uncontrollably.
New research from pharmaceutical sciences professor Richard Deth suggests a regulatory role for a well-known enzyme, and it may be impaired in autism.